As of September 30, 2026, Acutaas Chemicals Ltd carries a market capitalization of 268.47B, placing it among publicly traded companies globally. Its enterprise value stands at 266.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 268.47B |
| Enterprise Value | 266.18B |
Acutaas Chemicals Ltd's next confirmed earnings release is scheduled for February 14, 2027.
| Earnings Date | 2/14/2027 |
As of September 30, 2026, Acutaas Chemicals Ltd has 81.87M shares outstanding.
| Shares Outstanding | 81.87M |
As of September 30, 2026, Acutaas Chemicals Ltd trades at a trailing price-to-earnings ratio of 61.13. The price-to-sales ratio is 16.97, and the price-to-book ratio stands at 14.45.
| PE Ratio | 61.13 |
| PS Ratio | 16.97 |
| PB Ratio | 14.45 |
| P/TBV Ratio | 15.37 |
As of September 30, 2026, Acutaas Chemicals Ltd trades at an EV/EBITDA multiple of 42.67 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 16.82 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 45.75 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 266.18B versus a market cap of 268.47B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 16.82 |
| EV / EBITDA | 42.67 |
| EV / EBIT | 45.75 |
As of September 30, 2026, Acutaas Chemicals Ltd maintains a current ratio of 3.99, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.79, indicating moderate leverage, while an interest coverage ratio of 169.03 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.99 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 169.03 |
These figures cover the twelve months ended September 30, 2026. The company generates approximately 9.58M in revenue per employee across its workforce of 1,651.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 9.58M |
| Employee Count | 1,651.00 |
Over the twelve months ended September 30, 2026, Acutaas Chemicals Ltd recorded 1.61B in income tax expense. That works out to an effective tax rate of 26.86, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 6.00B, leaving 4.39B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 1.61B |
| Effective Tax Rate | 26.86 |
As of the close on November 17, 2026, Acutaas Chemicals Ltd's stock has gained approximately 130.81% over the past 52 weeks. The 50-day moving average sits at 3,447.37, while the 200-day moving average is 2,952.49.
| 52-Week Price Change | 130.81% |
| 50-Day Moving Average | 3,447.37 |
| 200-Day Moving Average | 2,952.49 |
Over the twelve months ended September 30, 2026, Acutaas Chemicals Ltd generated 15.82B in revenue and converted that into 4.39B in net income, yielding earnings per share of 53.36. EBITDA reached 6.24B, while operating income came in at 5.82B.
| Revenue | 15.82B |
| Gross Profit | 8.93B |
| Operating Income | 5.82B |
| Pretax Income | 6.00B |
| Net Income | 4.39B |
| EBITDA | 6.24B |
| EBIT | 5.82B |
| Earnings Per Share (EPS) | 53.36 |
As of September 30, 2026, Acutaas Chemicals Ltd holds 3.07B in cash and equivalents against 151.49M in total debt, resulting in a net debt position of -2.83B. Total book value stands at 18.57B, with working capital of 7.59B providing operational flexibility.
| Cash & Cash Equivalents | 3.07B |
| Total Debt | 151.49M |
| Net Debt | -2.83B |
| Equity (Book Value) | 18.57B |
| Book Value Per Share | 226.87 |
| Working Capital | 7.59B |
Over the twelve months ended September 30, 2026, Acutaas Chemicals Ltd posted a gross margin of 56.43, reflecting its pricing power and cost economics. The operating margin of 36.77 and net profit margin of 27.76 provide insight into operational efficiency.
| Gross Margin | 56.43 |
| Operating Margin | 36.77 |
| Pretax Margin | 37.91 |
| Profit Margin | 27.76 |
| EBITDA Margin | 39.43 |
Acutaas Chemicals Ltd's most recent stock split took place on April 25, 2025 with a 1:2 split ratio.
| Last Split Date | 4/25/2025 |
| Split Ratio | 1:2 |
Already premium?